Qvanteq

Biotechnology, Developer Platform, Medical
Founded in 2009-01-01
Zürich, Zurich, Switzerland
For Profit

About Qvanteq

Qvanteq is a medtech startup company, developing novel bioactive stents to address and overcome the clinical adverse effects of today’s available coronary and endovascular stents. Its bioactive Qstent controls in-growth therefore reducing the risk of restenosis and thrombosis. The company was awarded with the CTI start-up label in 2012. Qvanteq was founded in 2009 and is held by private investors. The ISO 13485 certified company is based in Zürich, Switzerland. It is a spin-off company from the Swiss Federal Institute of Technology, Zurich.

Company Metrics

  • Employees: 1-10
  • Monthly Visits: None
  • Tech Stack: 10 active products

Financial Information

  • Estimated Revenue:
  • Total Funding: 4010000 CHF
  • Last Funding: 4000000 CHF (Series B)
  • Funding Status: Early Stage Venture

Technology Stack

Qvanteq actively uses 10 products in their tech stack.

Market Presence

Industries: Biotechnology, Developer Platform, Medical

Headquarters: Zürich, Zurich, Switzerland